Talon Private Wealth LLC Lowers Position in Colgate-Palmolive Company $CL

Talon Private Wealth LLC decreased its stake in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 80.5% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,418 shares of the company’s stock after selling 10,006 shares during the quarter. Talon Private Wealth LLC’s holdings in Colgate-Palmolive were worth $222,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of CL. Brandywine Financial Group raised its holdings in shares of Colgate-Palmolive by 35,612.3% during the 1st quarter. Brandywine Financial Group now owns 72,853 shares of the company’s stock worth $6,209,000 after acquiring an additional 72,649 shares in the last quarter. Flputnam Investment Management Co. grew its holdings in shares of Colgate-Palmolive by 7.4% in the fourth quarter. Flputnam Investment Management Co. now owns 200,972 shares of the company’s stock valued at $15,881,000 after purchasing an additional 13,804 shares in the last quarter. SEB Asset Management AB purchased a new position in shares of Colgate-Palmolive in the first quarter valued at $91,149,000. Conning Inc. increased its position in Colgate-Palmolive by 10.2% in the fourth quarter. Conning Inc. now owns 426,753 shares of the company’s stock worth $33,722,000 after purchasing an additional 39,655 shares during the last quarter. Finally, AMI Asset Management Corp raised its stake in Colgate-Palmolive by 17.8% during the first quarter. AMI Asset Management Corp now owns 498,079 shares of the company’s stock valued at $42,451,000 after purchasing an additional 75,262 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Get Colgate-Palmolive alerts:

Key Headlines Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: A sale could generate cash, simplify Colgate-Palmolive’s brand portfolio and allow management to focus resources on faster-growing or higher-priority categories. The company is reportedly evaluating strategic options for some personal-care assets. Colgate-Palmolive seeks to divest some personal care brands, sources say
• Positive Sentiment: Royal Bank of Canada assigned Colgate-Palmolive an “Outperform” rating, while a separate analyst article described the company as recovering, offering some support for the stock’s longer-term investment case. Colgate-Palmolive Earns Outperform Rating from Royal Bank Of Canada
• Neutral Sentiment: Reports indicate that Goldman Sachs may be involved in exploring potential transactions, but the discussions remain preliminary and there is no announced deal or confirmed buyer. Did Colgate strike a new deal?
• Negative Sentiment: Colgate-Palmolive is reportedly considering the sale of mass-market brands including Softsoap, Irish Spring and Speed Stick. Investors may view the move as a sign that the businesses face limited growth or that management is changing its portfolio strategy, contributing to the stock’s decline. Colgate-Palmolive Stock Dips on Plan to Sell Personal Care Brands

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Barclays lifted their price objective on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. UBS Group upped their target price on shares of Colgate-Palmolive from $106.00 to $109.00 and gave the company a “buy” rating in a research report on Monday, August 3rd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Royal Bank Of Canada reissued an “outperform” rating and set a $104.00 price objective on shares of Colgate-Palmolive in a research note on Tuesday. Finally, Piper Sandler upped their price objective on Colgate-Palmolive from $92.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. Twelve investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $99.00.

Get Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Trading Down 1.4%

CL stock opened at $86.68 on Friday. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The stock has a market capitalization of $69.10 billion, a price-to-earnings ratio of 34.40, a price-to-earnings-growth ratio of 4.10 and a beta of 0.33. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. The firm’s fifty day simple moving average is $91.34 and its two-hundred day simple moving average is $89.61.

Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The firm had revenue of $5.36 billion during the quarter, compared to analyst estimates of $5.36 billion. During the same quarter last year, the business earned $0.92 EPS. The business’s revenue was up 4.9% on a year-over-year basis. As a group, analysts anticipate that Colgate-Palmolive Company will post 3.87 earnings per share for the current year.

Insider Buying and Selling

In related news, Director John Cahill sold 4,170 shares of the stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $93.37, for a total value of $389,352.90. Following the sale, the director directly owned 28,373 shares of the company’s stock, valued at $2,649,187.01. This represents a 12.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Panagiotis Tsourapas sold 10,000 shares of the firm’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $92.05, for a total transaction of $920,500.00. Following the completion of the sale, the chief operating officer directly owned 64,901 shares of the company’s stock, valued at approximately $5,974,137.05. The trade was a 13.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 175,191 shares of company stock valued at $16,110,903 in the last ninety days. 0.43% of the stock is owned by company insiders.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company (NYSE:CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its products are sold in more than 200 countries and territories through retail stores, e-commerce channels and professional networks.

The company’s portfolio includes Colgate toothpaste, toothbrushes and mouthwashes; Palmolive and Softsoap personal care products; Ajax and other household cleaning products; and Hill’s Science Diet and Prescription Diet pet foods.

Featured Articles

• Five stocks we like better than Colgate-Palmolive
• Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
• Kroger’s Textbook Entry for Buy-and-Hold Investors
• AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
• Amgen Drops 10% on a Trial It Didn’t Even Run

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.